Plerixafor
- 2 independent labs
- Animals2
- Cells1
Outcomes
4Cell viability
no changein human cells1
1 study
Cell viability
no changein human cells1
Plerixafor has no effect on cell viability in human cells.
“CXCR4 inhibition had no detrimental effects on chondrocyte viability, proliferation, or chondrogenic differentiation potential”
Cellsin isolated human articular chondrocytes exposed to 200 ng/mL CXCL12cartilage
Arthritis research & therapy2 Dec 2025
Cognitive function
upin mice1
1 study
Cognitive function
upin mice1
Plerixafor improves cognitive function in mice.
“significantly improved synaptic plasticity and cognitive performance in aged surgical mice”
Animalsin aged surgical micehippocampal CA1 region
Cell biology and toxicology3 Oct 2025
Inflammation
downin mice1
1 study
Inflammation
downin mice1
Plerixafor decreases inflammation in mice.
“both astrocyte-specific CXCR7 overexpression in the hippocampal CA1 region and systemic administration of the CXCR7 agonist AMD3100 effectively attenuated astrocyte activation, reduced neuroinflammation”
Animalsin aged surgical micehippocampal CA1 region
Cell biology and toxicology3 Oct 2025
Reactive astrocytes
downin mice1
1 study
Reactive astrocytes
downin mice1
Plerixafor decreases reactive astrocytes in mice.
“both astrocyte-specific CXCR7 overexpression in the hippocampal CA1 region and systemic administration of the CXCR7 agonist AMD3100 effectively attenuated astrocyte activation”
Animalsin aged surgical micehippocampal CA1 region
Cell biology and toxicology3 Oct 2025
Latest
1 in 12 monthsArthritis Research & Therapy
Targeting the CXCL12/CXCR4 pathway by an optimized derivative or EPI-X4 preserves chondrocyte function and offers a novel therapeutic approach in rheumatic diseases
Experiments in human cellsInterventions
Colloids and Surfaces B, Biointerfaces
Fe-Mn-IGF-AMD nanoparticles in accurate detection and treatment of liver cirrhosis via regulating relaxation coefficients and attenuating hepatocyte senescence
Experiments in animalsLiver cirrhosis